focus -WSS

focus

author：focus 2025-09-27 09:54:27 - browse：9937

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

explore

WSS

Physicians and social media: If you see something, say something?

Stories you might have missed in 2023: health, science, medicine

Life science postdocs should get big pay hike, NIH panel says

AstraZeneca to buy developer of next

American taxpayers paid $1.8 trillion in health care costs in 2022

Positive childhood experiences can help future health

Wikipedia

focus

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

Stop the failed accountable care organization experiment

As demand for Covid shots wanes, Moderna seeks its next success

JPM pitch from hospitals? Revenue streams outside of patient care

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Merck to acquire Harpoon Therapeutics for $680 million

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

UnitedHealth increases loan offers after Change Healthcare outage

New air purifier tech could be key to improving indoor air quality

Fauci's latest grilling in Congress: 9 hours, behind closed doors

explore

Stories you might have missed in 2023: health, science, medicine

SCOTUS questions limit to govt efforts to fight misinformation

Arena BioWorks launches in Cambridge to speed drug discovery

Study suggests new cause of Down syndrome: cells linked to aging

Life science postdocs should get big pay hike, NIH panel says

JPM pitch from hospitals? Revenue streams outside of patient care

knowledge

entertainment

explore

hotspot